1. Home
  2. SIM vs ABCL Comparison

SIM vs ABCL Comparison

Compare SIM & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Simec S.A.B. de C.V.

SIM

Grupo Simec S.A.B. de C.V.

N/A

Current Price

$22.03

Market Cap

4.6B

Sector

Industrials

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$9.73

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIM
ABCL
Founded
1969
2012
Country
Mexico
Canada
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.1B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
SIM
ABCL
Price
$22.03
$9.73
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $18.69
AVG Volume (30 Days)
1.1K
★ 2.8M
Earning Date
10-28-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 10.91
EPS
★ N/A
N/A
Revenue
N/A
★ $75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.74
P/E Ratio
$32.88
★ N/A
Revenue Growth
N/A
★ 160.56
52 Week Low
$23.16
$2.75
52 Week High
$34.35
$14.98

Technical Indicators

Market Signals
Indicator
SIM
ABCL
Relative Strength Index (RSI) 31.60 33.61
Support Level N/A $3.45
Resistance Level $27.56 $12.91
Average True Range (ATR) 0.65 0.84
MACD -0.48 -0.22
Stochastic Oscillator 0.00 1.84

Price Performance

Historical Comparison
SIM
ABCL

About SIM Grupo Simec S.A.B. de C.V.

Grupo Simec SAB de CV is a diversified producer, processor and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States of America. The maximum of its sales is from the Mexico segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: